Literature DB >> 4978352

Carbenicillin resistance in Pseudomonas aeruginosa from clinical material.

J H Darrell, P M Waterworth.   

Abstract

Strains of Pseudomonas aeruginosa resistant to 256 mug. per ml. or more of carbenicillin (Pyopen) were isolated from 17 patients over a period of three months. The infections were not solely due to cross-infection. Low dosage and attempted eradication of the organism from inaccessible sites, such as the bronchi or skin surfaces, by using systemic treatment are two possible causes. Restraint in treating infections of doubtful importance and the use of local applications to appropriate sites with or without systemic treatment is suggested.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4978352      PMCID: PMC1983956          DOI: 10.1136/bmj.3.5663.141

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  The reactions of bacteria to chemotherapeutic agents.

Authors:  L P GARROD
Journal:  Br Med J       Date:  1951-02-03

2.  Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea.

Authors:  W Brumfitt; A Percival; D A Leigh
Journal:  Lancet       Date:  1967-06-17       Impact factor: 79.321

3.  Bacteriological observations on carbenicillin in the control of Pseudomonas aeruginosa infection in burns.

Authors:  C E Van Rooyen; J F Ross; G W Bethune; A C MacDonald
Journal:  Can Med Assoc J       Date:  1967-11-11       Impact factor: 8.262

4.  Typing of Pseudomonas pyocyanea by pyocine production.

Authors:  R R Gillies; J R Govan
Journal:  J Pathol Bacteriol       Date:  1966-04

5.  The treatment of infections due to Pseudomonas aeruginosa with carbenicillin ("Pyopen").

Authors:  B C Stratford
Journal:  Med J Aust       Date:  1968-11-16       Impact factor: 7.738

6.  Experiences with carbenicillin in the treatment of septicaemia and meningitis.

Authors:  A E Richardson; K W James; C R Spittle; O P Robinson
Journal:  Postgrad Med J       Date:  1968-11       Impact factor: 2.401

  6 in total
  16 in total

1.  Gentamicin in urinary infections.

Authors:  J H Darrell
Journal:  Br Med J       Date:  1972-11-18

2.  Pseudomonas resistance due to inactivated susceptibility disks.

Authors:  L J Griffith
Journal:  Antimicrob Agents Chemother       Date:  1973-12       Impact factor: 5.191

Review 3.  Bacterial infection in the fetus and newborn.

Authors:  P A Davies
Journal:  Arch Dis Child       Date:  1971-02       Impact factor: 3.791

4.  Emergence of gentamicin- and carbenicillin-resistant Pseudomonas aeruginosa in a hospital environment.

Authors:  W Gaman; C Cates; C F Snelling; B Lank; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

5.  In vitro studies of semisynthetic alpha-(substituted-ureido) penicillins.

Authors:  G P Bodey; D Stewart
Journal:  Appl Microbiol       Date:  1971-04

6.  Clinical and pharmacological studies of ticarcillin in gram-negative infections.

Authors:  F R Ervin; W E Bullock
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

7.  Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.

Authors:  R M Kluge; H C Standiford; B Tatem; V M Young; W H Greene; S C Schimpff; F M Calia; R B Hornick
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

8.  Sensitivity to carbenicillin and ticarcillin, and the beta-lactamases of Pseudomonas aeruginosa in the UK in 1978-79.

Authors:  J D King; T Farmer; C Reading; R Sutherland
Journal:  J Clin Pathol       Date:  1980-03       Impact factor: 3.411

9.  Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse.

Authors:  G L Simon; D R Snydman; F P Tally; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

10.  Comparative activities of norfloxacin and fifteen other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa strains.

Authors:  K R Forward; G K Harding; G J Gray; B A Urias; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.